AMRN:NASDAQ
Amarin Corporation PLC
$12.13
arrow_upward
+0.17%(+0.020) 1D
Nov 2, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AMRN...
Open
$12.11
High
$12.27
Low
$11.85
Mkt. cap
256.22M
Avg. vol.
68.13K
Volume
0.00
52-wk high
$17.31
52-wk low
$11.25
EPS
-$1.30
Beta
0.76
Shares outstanding
21.07M
No. of employees
80
Open
$12.11
High
$12.27
Low
$11.85
Mkt. cap
256.22M
Avg. vol.
68.13K
Volume
0.00
52-wk high
$17.31
52-wk low
$11.25
EPS
-$1.30
Beta
0.76
Shares outstanding
21.07M
No. of employees
80
News stories
From web sources and news partners
Investing.com
·
19 minutes ago
STARTRADER Spotlights ANTHUSD Pre-IPO CFD as Anthropic Files to List on Nasdaq By FinanceWire
Yahoo Finance
·
1 hour ago
Stock Market: Will S&P 500 Open Up or Down Today?
Financial Times
·
1 hour ago
A new threat to the New York-based stock exchanges
Bloomberg.com
·
4 hours ago
Nasdaq Slide Clouds Asian Open, Oil Falls on Iran: Markets Wrap
Profile
Amarin Corporation is an Irish-American biopharmaceutical company founded in 1993 and headquartered in Dublin, Ireland and Bridgewater, New Jersey. The company develops and markets medicines for the treatment of cardiovascular disease. It has developed the drug Vascepa, a prescription grade omega-3 fatty acid.
In July 2012, their lead-candidate drug named Vascepa received FDA-approval, competing against GlaxoSmithKline's Lovaza. Wikipedia
About Amarin Corporation PLC
CEO-
Employees80
FoundedMar 1, 1989
HeadquartersDublin, Leinster, Ireland
SectorBiotechnology
Websiteamarincorp.com